Fulcrum Therapeutics (FULC) PT Raised to $12 at Morgan Stanley
Tweet
Share
E-mailGet Alerts FULC Hot Sheet
Price: $3.71 --0%
Rating Summary:
4 Buy, 7 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 8
Rating Summary:
4 Buy, 7 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 8
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Fulcrum Therapeutics (NASDAQ: FULC) to $12.00 (from $11.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Blaize Inc. (BZAI) PT Lowered to $2 at Rosenblatt
- Nu Holdings (Nubank) (NU) PT Raised to $19 at Needham
- Nuscale Power (SMR) PT Lowered to $15 at B.Riley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
